Swedish Orphan Biovitrum AB (publ) (LON: 0MTD)
London
· Delayed Price · Currency is GBP · Price in SEK
336.68
-1.11 (-0.33%)
At close: Jan 31, 2025
Swedish Orphan Biovitrum AB Revenue
Swedish Orphan Biovitrum AB had revenue of 6.89B SEK in the quarter ending September 30, 2024, with 33.40% growth. This brings the company's revenue in the last twelve months to 25.44B, up 19.58% year-over-year. In the year 2023, Swedish Orphan Biovitrum AB had annual revenue of 22.12B with 17.74% growth.
Revenue (ttm)
25.44B SEK
Revenue Growth
+19.58%
P/S Ratio
n/a
Revenue / Employee
14.35M SEK
Employees
1,772
Market Cap
8.39B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
Dec 31, 2019 | 14.25B | 5.11B | 55.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |